Q-omics provides the consensus-scored MTCYBP10 profile across patient tissues and cancer cell-line models. MTCYBP10 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, MTCYBP10 RNA expression shows 3,108 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where MTCYBP10 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTCYBP10 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTCYBP10 survival associations across molecular data types. MTCYBP10 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTCYBP10 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	KIRC (105)	view →

This table ranks reproducible MTCYBP10 RNA expression–survival associations across cancer types. High MTCYBP10 expression shows unfavorable associations in KIRC, COAD, MESO, LUSC, LIHC and THCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for MTCYBP10 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.159	0.634	<.001	105	view →
COAD	OS	Tertile	III,IV	0.272	0.703	.001	69	view →
MESO	OS	Tertile	All	0.130	0.557	.019	54	view →
LUSC	OS	Tertile	II,III,IV	0.182	0.742	<.001	42	view →
LIHC	DFS	Tertile	III,IV	0.073	0.364	<.001	42	view →
THCA	OS	Tertile	All	0.939	0.991	.005	33	view →

Pink = unfavorable, green = favorable. all 11 lineages →

MTCYBP10-KIRC (DFS)

Kaplan–Meier survival curve for MTCYBP10 RNA expression in KIRC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTCYBP10 in patient tissues and cancer cell lines. In patient samples, MTCYBP10 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	3,108	STAD (2405)	view →
RNA	3,065	UCEC (898)	view →